最新观点
Insights From Our Experts
Articles
Improving the Patient Experience with Digital Tools
EVERSANA’s Patient Services expert, Skyler Vise, Senior Director, Client & Delivery Excellence, EVERSANA, and Ida Goldstein, Senior Director, Trade, Distribution, and Patient Services, Mirum Pharmaceutical, presented at Access USA covering how digital tools can improve the…
A Framework for Branded Pharma Companion Apps Is Coming Soon
The FDA just announced plans to release a draft guidance on prescription drug-use-related software later this year. What should the pharma industry expect? The past three years have seen a significant increase in the acceptance and…
When Will “Digital Health” Just Become Health?
Despite the significant drop in funding in 2022, digital health is here to stay. It encompasses a wide range of technologies and innovations, from telemedicine to wearables to artificial intelligence (AI). Telehealth has reached 80% adoption…
Breaking Down Q1 2023 Digital Health Policy Updates
Insights and Implications on AI/ML Software, Companion Apps for Pharma, Digital Diagnostics, VR Software, Breakthrough Devices, and More There was a barrage of activity by FDA in Digital Health at the end of 2022, including the…
Bringing a CPT Code to Life to Help in the Fight Against Cancer
An interview with Navid Alipour, CEO of CureMatch, and Brian Abraham, Sr. Director, Market Access & Patient Services with EVERSANA On January 1, CureMatch, a leader in precision medicine that has developed a unique analytical platform…
Can Telehealth Accelerate the Uptake of Digital Therapeutics?
Introducing an industry-first, integrated direct-to-patient telehealth solution for digital therapeutics that includes patient engagement, telehealth consultation, prescription issuing and dispensing, and patient support. Fueled by the pandemic, telehealth has moved from an interest to expectation for…
Rounding Up FDA’s Digital Health Actions from 2022 and Looking Forward to 2023
The healthcare sector continued the digitization evolution in 2022. Among the many product launches and technological advances, a recent report from AMA showed that 93% of physicians now see digital health tools as advantageous to patient…
8 Healthtech Trends For 2023
2023 is here, and with it comes foreshadowing of what the year will bring. In the life sciences and pharmaceutical industry, it’s not different. In fact, many have already made their predictions for the new year,…
Seven Important Factors for APAC Companies to Consider while Launching Products in the Digital Health and Digital Therapeutics Space
Digital health and digital therapeutics innovation, commercialization, and adoption is accelerating in the APAC region. Digital medicines as an area, globally, is not new, yet even the largest players in the sector can still be considered…
Regulatory Framework for Digital Therapeutics in the APAC Region
Authored by: Martin Culjat, Kory Dillman, Deval Patel Digital health and digital therapeutics innovation, commercialization, and adoption is accelerating in the APAC region, and this has been in full display at the first-ever DTx Asia conference…